XML 21 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements Of Cash Flows
12 Months Ended
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Cash Flows From Operating Activities:      
Net income $ 41,573,000 $ 35,122,000 $ 30,880,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision (credit) for loan losses (1,755,000) 4,854,000 3,480,000
Provision (credit) for deferred income taxes (1,601,000) 1,114,000 1,233,000
Provision for losses on other real estate owned   725,000  
Depreciation and amortization 4,068,000 3,604,000 3,219,000
Premium amortization on investment securities, net 1,714,000 3,045,000 4,002,000
Net (losses) gains on sales of securities 10,406,000 1,866,000 (1,868,000)
Net gain on sale of premises and equipment (1,176,000)    
Loss on debt extinguishment     1,756,000
Stock-based compensation expense 1,814,000 2,434,000 1,517,000
Accretion of cash surrender value on bank-owned life insurance (2,134,000) (1,568,000) (932,000)
Pension expense (credit) less contribution (319,000) (118,000) (1,536,000)
Increase (decrease) in accrued expenses and other liabilities 4,002,000 1,031,000 (3,313,000)
Other decreases (increases) 2,782,000 (4,937,000) (2,849,000)
Net cash provided by operating activities 59,374,000 47,172,000 35,589,000
Proceeds from sales of investment securities:      
Held-to-maturity   355,000 123,000
Available-for-sale 263,994,000 135,695,000 62,047,000
Proceeds from maturities and redemptions of investment securities:      
Held-to-maturity 5,240,000 6,089,000 4,322,000
Available-for-sale 74,639,000 100,994,000 108,486,000
Purchases of investment securities:      
Held-to-maturity (3,059,000) (2,606,000) (1,403,000)
Available-for-sale (397,174,000) (144,885,000) (267,329,000)
Proceeds from sales of loans held-for-sale 1,250,000   544,000
Proceeds from sale of real estate 6,793,000    
Net increase in loans (315,389,000) (411,908,000) (298,361,000)
Net increase in restricted stock (3,372,000) (5,551,000) (3,328,000)
(Purchases of) proceeds from bank-owned life insurance, net (18,561,000) (25,000,000) 388,000
Purchases of premises and equipment, net (5,687,000) (8,891,000) (7,250,000)
Net cash used in investing activities (391,326,000) (355,708,000) (401,761,000)
Cash Flows From Financing Activities:      
Net increase in deposits 262,975,000 213,280,000 324,042,000
Net increase (decrease) in short-term borrowings 107,782,000 74,129,000 (4,490,000)
Proceeds from long-term debt 39,680,000 71,635,000 43,500,000
Repayment of long-term debt (101,450,000) (27,050,000) (31,756,000)
Proceeds from issuance of common stock, net 18,239,000 22,598,000 43,712,000
Proceeds from exercise of stock options 312,000 917,000 906,000
Repurchases of common stock (1,541,000)    
Shares withheld upon the vesting and conversion of RSUs (774,000) (527,000) (370,000)
Cash dividends paid (15,585,000) (13,703,000) (12,078,000)
Net cash provided by financing activities 309,638,000 341,279,000 363,466,000
Net (decrease) increase in cash and cash equivalents (22,314,000) 32,743,000 (2,706,000)
Cash and cash equivalents, beginning of year 69,672,000 36,929,000 39,635,000
Cash and cash equivalents, end of period 47,358,000 69,672,000 36,929,000
Supplemental Cash Flow Disclosures:      
Cash paid for interest 35,274,000 21,545,000 21,158,000
Cash paid for income taxes 2,490,000 12,838,000 9,006,000
Noncash investing and financing activities:      
Cash dividends payable 4,456,000 3,798,000 $ 3,368,000
Additions to other real estate owned   $ 5,850,000  
Loans transferred from portfolio to held-for-sale $ 1,151,000